Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ·Healthcare·Biotechnology
$3.36
-1.32%
Mkt Cap $276.33M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+49.0%
Consensus $5.00 vs current $3.36
NASDAQ·Healthcare·Biotechnology
$3.36
-1.32%
Mkt Cap $276.33M
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
+49.0%
Consensus $5.00 vs current $3.36